Volume 19, Issue 10 pp. 1965-1968
Short Paper
Full Access

T cell activation: independent induction of killing activity and interleukin 2 secretion in cytolytic hybridomas*

Tali Ozery

Tali Ozery

Institute of Hematology, The Chaim Sheba Medical Center, Tel Hashomer

Search for more papers by this author
Gideon Berke

Gideon Berke

The Sackler School of Medicine, Tel Aviv University, Tel Aviv

Search for more papers by this author
Miriam Moscovich

Miriam Moscovich

The Sackler School of Medicine, Tel Aviv University, Tel Aviv

Search for more papers by this author
Keiko Ozato

Keiko Ozato

Department of Cell Biology, The Weizmann Institute of Science, Rehovot and National Institute of Child Health and Human Development, National Institute of Health, Bethesda

Search for more papers by this author
Yael Kaufmann

Corresponding Author

Yael Kaufmann

Institute of Hematology, The Chaim Sheba Medical Center, Tel Hashomer

Institute of Hematology, The Chaim Sheba Medical Center, Tel Hashomer 52621, IsraelSearch for more papers by this author
First published: October 1989
Citations: 2

Abstract

Memory-like cytotoxic T lymphocytes (CTL) hybridomas exhibiting inducible killing activity and IL2 production were used to analyze the anamnestic response of CTL. Four activating agents were examined; anti-Thy-1 monoclonal antibody G7, staphylococcal enterotoxin B, interferon (IFN)-α/β and IFN-γ. These agents seemed to affect CTL activities in three distinct ways. Anti-Thy-1 monoclonal antibody, like specific antigen, was found to be a potent inducer of specific killing and IL2 production, whereas staphylococcal enterotoxin B induced IL2 production, but not cytolytic activity. On the other hand, IFN-α/β and IFN-γ effectively stimulated cytotoxicity without inducing IL2 production. The independent triggering of specific killing and IL2 secretion in the monoclonal cytolytic hybridomas suggests that in CTL distinct signals stimulate killing activity and IL2 production. The results also suggest that IFN-α/β and IFN-γ trigger the cytolytic program through an alternative activation pathway which does not involve the T cell receptor.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.